Print page content Print
Increase text size Decrease text size
Text Size
  • Proven Efficacy
  • Dosing & Administration
  • Tools & Resources
  • Prescribing Information
  • EXCEDE® delivers powerful, proven BRD treatment.

    After bovine respiratory disease (BRD) metaphylaxis, if you want your first antimicrobial treatment to be your last, rely on EXCEDE® (ceftiofur crystalline free acid)188体育平台 Sterile Suspension:

    • Delivers up to seven days of BRD therapy in a single dose
    • Controls and treats three major BRD pathogens
    • Better 56-day treatment success than Baytril® (enrofloxacin)1
    • Resulted in fewer treatment failures than Baytril1
    • Delivers one of the lowest treatment costs per day
    • Offers the convenience of a short, 13-day meat withdrawal

    Excede Approval Chart Link to research >


    See why EXCEDE delivers proven efficacy> 


    IMPORTANT SAFETY INFORMATION FOR CATTLE: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCEDE. EXCEDE is contraindicated in animals with known allergy to ceftiofur or to the ß-lactam group (penicillins and cephalosporins) of antimicrobials. Inadvertent intra-arterial injection is possible and fatal. Do not use in calves to be processed for veal. Pre-slaughter withdrawal time is 13 days following the last dose. See full Prescribing InformationOpens in a new window.







    We are Mon–Fri, 8:30am–8:00pm ET

    zoetis logo United States flag United States

    This site is intended for U.S. Animal Healthcare Professionals. The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries. The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

    All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. ©2020 Zoetis Services LLC. All rights reserved.

    优发体育国际 电竞竞猜软件 久发国际 雅虎娱乐 添运国际登陆 乐虎体育官网 山水娱乐官网 u乐平台官网 必赢官网 大发体育官网